Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Lymphoma
  •  Immunology
  •  Haemato-Oncology
  •  Targeted Therapy
  •  Hematology
  •  Breast Cancer
  •  Central Nervous System Tumors
  •  Neoadjuvant Therapy

Abstract

Citation: Clin Oncol. 2021;6(1):1810.DOI: 10.25107/2474-1663.1810

Primary Breast Lymphoma: Case Report

Estefanía Ruiz Alcaide, Joaquín Navarro Castellón, Paula Sáez Bueno, Andrea Matas Escamilla, Zigor Zalabarria Zarrabeitia, Marta Domínguez Morcillo, Eliseo Carrasco Esteban, Carmen Ibáñez Villoslada and María Concepción López-Carrizosa

Department of Radiation Oncology, Central Defense "Gomez Ulla" Hospital, Spain

*Correspondance to: María Concepción López-Carrizosa 

 PDF  Full Text Case Report | Open Access

Abstract:

Primary Breast Lymphomas (PBL) are a rare entity of non-Hodgkin's lymphomas which usually appear in women. Usually, the main sign is a palpable mass in the breast, although it can also be asymptomatic. The treatment is mainly chemotherapy and consolidation radiotherapy.
We present a case report of a woman who treated in our hospital for a breast mass and was diagnosed of PBL.

Keywords:

Non-Hodgkin lymphoma; Diffuse large B-cell lymphoma; Radiotherapy; R-CHOP; Breast cancer; Primary breast lymphoma

Cite the Article:

Alcaide ER, Castellón JN, Bueno PS, Escamilla AM, Zarrabeitia ZZ, Morcillo MD, et al. Primary Breast Lymphoma: Case Report. Clin Oncol. 2021;6:1810..

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Multifocal Pancreatic and Liver PEComas Mimic Metastatic Tumors: Case Report and Literature Review
 Abstract  PDF  Full Text
PEGylation of AS16 Double-Target Peptide that Blocks the Neuropilin-1 and Tie2 Signaling Pathways Enhances its Antitumor Effect
 Abstract  PDF  Full Text
View More...